Yoji Honda Selected Research

Yoji Honda Research Topics

12	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 01/2012
7	Neoplasms (Cancer) 10/2022 - 07/2013
3	Infections 11/2017 - 01/2014
2	Neoplasm Metastasis (Metastasis) 10/2018 - 07/2016
2	Thrombosis (Thrombus) 01/2018 - 10/2014
2	Chronic Hepatitis C 11/2017 - 01/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2017 - 03/2017
1	Fever (Fevers) 01/2021
1	Disease Progression 01/2020
1	Chronic Hepatitis (Chronic Active Hepatitis) 03/2017
1	Fibrosis (Cirrhosis) 03/2017
1	Pathologic Constriction (Stenosis) 10/2014
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2013
1	Cysts 03/2013

4	lenvatinibIBA 10/2022 - 01/2020
4	Sorafenib (BAY 43-9006)FDA Link 10/2018 - 01/2012
2	daclatasvirIBA 03/2017 - 01/2014
2	Fetal Proteins (Fetoprotein)IBA 07/2016 - 01/2012
1	AlbuminsIBA 10/2022
1	BilirubinIBA 10/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	RamucirumabIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	regorafenibIBA 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020
1	ledipasvirIBA 11/2017
1	LipidsIBA 11/2017
1	sofosbuvir drug combination ledipasvirIBA 11/2017
1	SofosbuvirIBA 11/2017
1	asunaprevirIBA 03/2017
1	Fluorouracil (Carac)FDA LinkGeneric 07/2016
1	Ribavirin (Virazole)FDA LinkGeneric 01/2014
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2013
1	Ethiodized Oil (Ethiodol)FDA Link 07/2013
1	Praziquantel (Biltricide)FDA Link 03/2013